Schrödinger, Inc. (SDGR)

Market Cap	1.46B
Revenue (ttm)	207.54M
Net Income (ttm)	-187.12M
Shares Out	73.04M
EPS (ttm)	-2.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	856,357
Open	20.07
Previous Close	20.26
Day's Range	19.75 - 20.26
52-Week Range	16.67 - 29.15
Beta	1.62
Analysts	Buy
Price Target	32.29 (+61.77%)
Earnings Date	Apr 30, 2025

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 891
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR
• Website: https://www.schrodinger.com

Analyst Forecast

According to 7 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $32.29, which is an increase of 61.77% from the latest price.

Price Target

$32.29

(61.77% upside)

Analyst Consensus: Buy